EXAS
EXACT SCIENCES CORP
Key Financials
Net Income
$-207949000
↑ 79.8%
Operating Income
$-206298000
↑ 80.3%
Gross Profit
$2.3B
↑ 17.9%
Revenue
$3.2B
↑ 17.7%
Total Assets
$5.9B
↓ 1.1%
EPS (Diluted)
$-1.10
↑ 80.3%
Cash & Equivalents
$956.0M
↑ 59.1%
Shareholders' Equity
$2.4B
↓ 0.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | EXAS |
| Company Name | EXACT SCIENCES CORP |
| CIK | 1124140 |
| SIC Code | 8071 |
| SIC Description | Services-Medical Laboratories |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| Phone | 608-284-5700 |